Literature DB >> 24956988

Is there specific neurological disorders of primary Sjögren's syndrome?

Guillermo Carvajal Alegria1, Dewi Guellec1, Valérie Devauchelle-Pensec1, Alain Saraux2.   

Abstract

Neurological manifestations of primary Sjögren's syndrome are multiple and appear frequently. Depending on data analysis, patient recruitment, and diagnosis criteria used to defined primary Sjögren's syndrome or neurological manifestations, the estimated prevalence is between 0 and 70%. Peripheral neurological complications seem the most common, particularly sensory-motors axonal neuropathies. Neuronopathy seems to be the most specific neurological complication of primary Sjögren's syndrome. Central manifestations of primary Sjögren's syndrome are not uncommon, but the neurological complication's spectrum is not well defined. Neuromyelitis optica is regularly found among central complications. To conclude, although central and peripheral complications of primary Sjögren's syndrome are difficult to assess, partly because of the wide spectrum of possible manifestations, it is around 20%. Neuronopathy is still the most specific complication.
Copyright © 2014 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Neurology; Sjögren's syndrome

Mesh:

Year:  2014        PMID: 24956988     DOI: 10.1016/j.jbspin.2014.04.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

Review 1.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 2.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

3.  A case report of Sjögren syndrome manifesting bilateral basal ganglia lesions.

Authors:  Bing Niu; Zhenzhen Zou; Yuqin Shen; Bingzhen Cao
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Adjuvant rituximab improves sensory ataxia in CIDP-related Sjögren syndrome.

Authors:  Raquel Rocha; Filipe Correia; Andreia Santos; João Martins
Journal:  BMJ Case Rep       Date:  2020-08-26

5.  Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.

Authors:  Guillermo Carvajal Alegria; Dewi Guellec; Xavier Mariette; Jacques-Eric Gottenberg; Emmanuelle Dernis; Jean-Jacques Dubost; Anne-Priscille Trouvin; Eric Hachulla; Claire Larroche; Veronique Le Guern; Divi Cornec; Valérie Devauchelle-Pensec; Alain Saraux
Journal:  RMD Open       Date:  2016-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.